No Data
No Data
The "breeding heat" has led to an increase in piglet prices, listed pig companies are increasing piglet sales, and pasture companies are emerging丨Industry dynamics.
① Recently, the price of piglets has risen for three consecutive weeks, leading listed pig enterprises to increase piglet sales; ② Currently, breeding sows are being concentrated in listed pig enterprises and group pig enterprises, while smallholders mainly focus on piglet fattening and secondary fattening, and free-range farming companies are on the rise.
Meinong Biotechnology (301156.SZ): plans to use no more than 90 million yuan of idle raised funds for Cash / Money Market management.
On March 18, Gelonghui announced that Meino Bio (301156.SZ) disclosed plans to improve the efficiency of the company's fund usage. This will be done while ensuring that the fundraising projects are not affected, the company's normal operations are not hampered, and the safety of funds is guaranteed. The plan intends to use no more than 90 million yuan (including this amount) of idle raised funds (including overraised funds) for cash management. The above amount will be valid from the expiration date of the cash management authorization approved at the fifth meeting of the fifth Board of Directors (i.e., April 6, 2025) until the day the relevant proposals are resolved at the next year's meeting, without exceeding the above amount.
The concerted action of major shareholder Tang Ling of Meino Biological (301156.SZ) plans to reduce their shareholding by no more than 1%.
Mei Nong Biological (301156.SZ) announced that 唐凌, a shareholder holding more than 5% of the shares, and his concerted actor 唐旭 plan to...
Shanghai Menon Animal Nutrition Unit Gets Green Light for New Corn Protein Plant
Mei Nong Biological (301156.SZ): A total of 2.6319% of shares have been repurchased.
On February 5, Guanglonghui reported that Meinan Biotechnology (301156.SZ) announced that as of January 27, 2025, the company has repurchased a total of 3,821,365 shares through the special securities account for share repurchase via centralized bidding, accounting for 2.6319% of the company's current total share capital, with the highest Fill Price at 16.69 yuan/share, the lowest Fill Price at 10.73 yuan/share, and a total transaction amount of 53,106,041.54 yuan (excluding transaction fees). This share repurchase complies with the company's established share repurchase plan and relevant laws and regulations.
Meinong Biology (301156.SZ): has cumulatively repurchased 1.48% of shares.
On December 2, GeLonghui reported that Meino Biological (301156.SZ) announced that as of November 29, 2024, the company had repurchased a total of 2,155,765 shares through a dedicated securities account for share buybacks via centralized bidding, accounting for 1.48% of the company's current share capital, with a highest fill price of 16.69 yuan/share, a lowest fill price of 10.73 yuan/share, and a total transaction amount of 30.29696 million yuan (excluding transaction fees).